Home

szag Vérzik szakasz teva pharmaceuticals news today Kád Bepiál színház

Teva Pharmaceutical will cut 7,000 jobs and close plants to reduce costs
Teva Pharmaceutical will cut 7,000 jobs and close plants to reduce costs

Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business  Wire
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire

Teva's two new digital inhalers complete Digihaler product line |  MobiHealthNews
Teva's two new digital inhalers complete Digihaler product line | MobiHealthNews

Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic  Times
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times

Sumitomo Mitsui Trust Holdings Inc. Decreases Holdings in Teva  Pharmaceutical Industries as Insider Sales Raise Questions - Best Stocks
Sumitomo Mitsui Trust Holdings Inc. Decreases Holdings in Teva Pharmaceutical Industries as Insider Sales Raise Questions - Best Stocks

Opioid firm Teva agrees $85m settlement days before Oklahoma case goes to  court | US News | Sky News
Opioid firm Teva agrees $85m settlement days before Oklahoma case goes to court | US News | Sky News

Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals found liable in New York opioid trial - BBC News

Teva Announces Launch of $2 Billion (Equivalent) Offering of  Sustainability-Linked Senior Notes - ESG News
Teva Announces Launch of $2 Billion (Equivalent) Offering of Sustainability-Linked Senior Notes - ESG News

Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals is found liable in the opioid crisis : NPR

Teva Pharmaceuticals found to be responsible for its role in the opioid  epidemic in New York State | CNN
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN

Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva to pay New York $500M for role in opioid crisis - POLITICO

Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York  Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times

Fresh woes emerge as Teva plunges to new lows - Globes
Fresh woes emerge as Teva plunges to new lows - Globes

Feds accuse Teva of $300M in kickbacks for MS drug - Drug Discovery and  Development
Feds accuse Teva of $300M in kickbacks for MS drug - Drug Discovery and Development

Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva Pharmaceutical to Nominate Four New Directors - WSJ

Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill

Teva looks to amp up research collaborations, CEO says
Teva looks to amp up research collaborations, CEO says

TEVA.N - | Stock Price & Latest News | Reuters
TEVA.N - | Stock Price & Latest News | Reuters

Teva bought the pharm, and now it may have bought the farm | The Times of  Israel
Teva bought the pharm, and now it may have bought the farm | The Times of Israel

Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva Pharmaceuticals Lays Off Half Its Israeli Workers

Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State

Teva Pharmaceuticals and MedinCell gain FDA approval for UZEDY, the first  subcutaneous, long-acting formulation of risperidone for the treatment of  schizophrenia in adults.
Teva Pharmaceuticals and MedinCell gain FDA approval for UZEDY, the first subcutaneous, long-acting formulation of risperidone for the treatment of schizophrenia in adults.

Teva buys Anda for $500 million - ISRAEL21c
Teva buys Anda for $500 million - ISRAEL21c

Catalyst stock slumps ~20% as Teva seeks FDA approval of generic Firdapse |  Seeking Alpha
Catalyst stock slumps ~20% as Teva seeks FDA approval of generic Firdapse | Seeking Alpha

Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO |  BioSpace
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace